ReShape Lifesciences EBIT Margin 2015-2025 | RSLS
Current and historical EBIT (Earnings Before Interest & Taxes) margin for ReShape Lifesciences (RSLS) over the last 10 years. The current EBIT profit margin for ReShape Lifesciences as of March 31, 2025 is .
| ReShape Lifesciences EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-03-31 | $0.01B | $-0.01B | -114.29% |
| 2024-12-31 | $0.01B | $-0.01B | -100.00% |
| 2024-09-30 | $0.01B | $-0.01B | -100.00% |
| 2024-06-30 | $0.01B | $-0.01B | -125.00% |
| 2024-03-31 | $0.01B | $-0.01B | -150.00% |
| 2023-12-31 | $0.01B | $-0.02B | -200.00% |
| 2023-09-30 | $0.01B | $-0.03B | -344.44% |
| 2023-06-30 | $0.01B | $-0.04B | -390.00% |
| 2023-03-31 | $0.01B | $-0.04B | -400.00% |
| 2022-12-31 | $0.01B | $-0.05B | -418.18% |
| 2022-09-30 | $0.01B | $-0.07B | -600.00% |
| 2022-06-30 | $0.01B | $-0.07B | -575.00% |
| 2022-03-31 | $0.01B | $-0.06B | -492.31% |
| 2021-12-31 | $0.01B | $-0.06B | -414.29% |
| 2021-09-30 | $0.02B | $-0.02B | -143.75% |
| 2021-06-30 | $0.02B | $-0.01B | -62.50% |
| 2021-03-31 | $0.01B | $-0.01B | -64.29% |
| 2020-12-31 | $0.01B | $-0.01B | -100.00% |
| 2020-09-30 | $0.01B | $-0.02B | -187.50% |
| 2020-06-30 | $0.00B | $-0.02B | -425.00% |
| 2020-03-31 | $0.00B | $-0.02B | -1000.00% |
| 2019-12-31 | $0.00B | $-0.02B | -766.67% |
| 2019-09-30 | $0.00B | $-0.03B | -675.00% |
| 2019-06-30 | $0.01B | $-0.03B | -428.57% |
| 2019-03-31 | $0.01B | $-0.03B | -340.00% |
| 2018-12-31 | $0.01B | $-0.04B | -422.22% |
| 2018-09-30 | $0.01B | $-0.04B | -354.55% |
| 2018-06-30 | $0.01B | $-0.04B | -372.73% |
| 2018-03-31 | $0.01B | $-0.04B | -390.00% |
| 2017-12-31 | $0.01B | $-0.04B | -350.00% |
| 2017-09-30 | $0.01B | $-0.03B | -471.43% |
| 2017-06-30 | $0.01B | $-0.03B | -560.00% |
| 2017-03-31 | $0.00B | $-0.02B | -600.00% |
| 2016-12-31 | $0.00B | $-0.02B | -475.00% |
| 2016-06-30 | $0.00B | $-0.01B | -333.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.011B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.157B | 22.16 |
| Intuitive Surgical (ISRG) | United States | $171.022B | 70.89 |
| IDEXX Laboratories (IDXX) | United States | $52.319B | 54.45 |
| Edwards Lifesciences (EW) | United States | $45.899B | 30.42 |
| Alcon (ALC) | Switzerland | $42.809B | 28.93 |
| IQVIA Holdings (IQV) | United States | $32.198B | 18.19 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.060B | 32.12 |
| STERIS (STE) | Ireland | $24.242B | 25.80 |
| Waters (WAT) | United States | $17.472B | 24.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.672B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.441B | 26.82 |
| Masimo (MASI) | United States | $8.250B | 27.76 |
| Globus Medical (GMED) | United States | $8.125B | 18.70 |
| Teleflex (TFX) | United States | $5.369B | 8.67 |
| Glaukos (GKOS) | United States | $5.223B | 0.00 |
| TransMedics (TMDX) | United States | $4.423B | 67.22 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.956B | 16.92 |
| Veracyte (VCYT) | United States | $2.363B | 32.65 |
| Alphatec Holdings (ATEC) | United States | $2.304B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.232B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.046B | 24.43 |
| Artivion (AORT) | United States | $2.027B | 102.26 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Pulse Biosciences (PLSE) | United States | $1.165B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.061B | 6.08 |
| IRadimed (IRMD) | United States | $0.892B | 43.30 |
| Beta Bionics (BBNX) | United States | $0.726B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.720B | 0.00 |
| AxoGen (AXGN) | United States | $0.686B | 0.00 |
| SiBone (SIBN) | United States | $0.660B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.549B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.520B | 4.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.509B | 8.98 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.50 |
| Pacific Biosciences Of California (PACB) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 87.25 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| RxSight (RXST) | United States | $0.336B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.276B | 19.05 |
| Alpha Tau Medical (DRTS) | Israel | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.235B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.092B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.16 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |